- Home
- RRGB vs QTTB Comparison
RRGB vs QTTB Comparison
Compare RRGB & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RRGB | QTTB |
|---|---|---|
| Founded | 1969 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 80.0M |
| IPO Year | 2002 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RRGB | QTTB |
|---|---|---|
| Price | $3.63 | $5.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $9.00 | ★ $13.00 |
| AVG Volume (30 Days) | 236.8K | ★ 261.2K |
| Earning Date | 05-28-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 73.43 | ★ 136.78 |
| EPS | N/A | ★ 2.42 |
| Revenue | ★ $1,315,014,000.00 | $53,737,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.08 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.46 | $1.40 |
| 52 Week High | $7.52 | $8.05 |
Technical Indicators
Market Signals| Indicator | RRGB | QTTB |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 41.09 |
| Support Level | $3.20 | $4.80 |
| Resistance Level | $4.41 | $7.69 |
| Average True Range (ATR) | 0.27 | 0.63 |
| MACD | -0.03 | -0.14 |
| Stochastic Oscillator | 19.49 | 10.57 |
Price Performance
Historical ComparisonAbout RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. The company's brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. It has one operating and one reportable segment: restaurants.
About QTTB Q32 Bio Inc.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).